It is largely known that uric acid is the final product of purine metabolism, and that its increased serum levels have been directly involved in the pathogenesis and natural history of a number of endocrino-metabolic and cardiovascular diseases. In particular, serum uric acid (SUA) has been associated with the risk of developing hypertension and subclinical vascular damage (2), as well as an increased risk of myocardial infarction, stroke, heart failure, and different arrhythmias (in particular atrial fibrillation) by affecting thickness, function, and other features of the vascular tissue. As regards metabolic diseases, SUA is not only associated with a risk of gout, but also metabolic syndrome, nonalcoholic fatty liver disease, obesity, and type 2 diabetes. The risk of type 2 diabetes macrovascular and microvascular complications are also associated with increased SUA levels.

Hu Y, Cicero AFG. (2023). Editorial: Serum uric acid, vascular aging, and endocrine comorbidities. FRONTIERS IN ENDOCRINOLOGY, 14, 1-2 [10.3389/fendo.2023.1292015].

Editorial: Serum uric acid, vascular aging, and endocrine comorbidities

Cicero AFG.
Ultimo
Conceptualization
2023

Abstract

It is largely known that uric acid is the final product of purine metabolism, and that its increased serum levels have been directly involved in the pathogenesis and natural history of a number of endocrino-metabolic and cardiovascular diseases. In particular, serum uric acid (SUA) has been associated with the risk of developing hypertension and subclinical vascular damage (2), as well as an increased risk of myocardial infarction, stroke, heart failure, and different arrhythmias (in particular atrial fibrillation) by affecting thickness, function, and other features of the vascular tissue. As regards metabolic diseases, SUA is not only associated with a risk of gout, but also metabolic syndrome, nonalcoholic fatty liver disease, obesity, and type 2 diabetes. The risk of type 2 diabetes macrovascular and microvascular complications are also associated with increased SUA levels.
2023
Hu Y, Cicero AFG. (2023). Editorial: Serum uric acid, vascular aging, and endocrine comorbidities. FRONTIERS IN ENDOCRINOLOGY, 14, 1-2 [10.3389/fendo.2023.1292015].
Hu Y; Cicero AFG.
File in questo prodotto:
File Dimensione Formato  
Hu Y_Editorial serum uric acid_Front Endocrinol.pdf

accesso aperto

Tipo: Versione (PDF) editoriale
Licenza: Licenza per Accesso Aperto. Creative Commons Attribuzione (CCBY)
Dimensione 233.85 kB
Formato Adobe PDF
233.85 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/953906
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact